Inicio › Cáncer de ovario › California
Ensayos clínicos de Cáncer de ovario en California
105 estudios sobre Cáncer de ovario buscan participantes en California.
Ciudades en California
- Los Angeles50 estudios
- Baldwin Park25 estudios
- San Diego24 estudios
- San Francisco19 estudios
- Mountain View19 estudios
- Orange16 estudios
- Santa Monica15 estudios
- Irvine12 estudios
- Newport Beach9 estudios
- Sacramento7 estudios
- Santa Rosa7 estudios
- Fullerton6 estudios
- Concord5 estudios
- Santa Barbara5 estudios
- Burbank4 estudios
- San Jose4 estudios
- Vallejo4 estudios
- Pleasanton4 estudios
- Fresno4 estudios
- Long Beach3 estudios
- Oakland3 estudios
- Roseville3 estudios
- Fremont3 estudios
- Arden-Arcade3 estudios
- Torrance3 estudios
- Richmond3 estudios
- Santa Clara3 estudios
- Modesto3 estudios
- Redwood City3 estudios
- Elk Grove3 estudios
- Antioch3 estudios
Texto oficial del estudio (inglés)
The Vanguard Study: Testing a New Way to Screen for Cancer
- Kaiser Permanente-Division of Research, Pleasanton
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06995898Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Los Angeles
- Research Site, San Francisco
ReclutandoFase 1/2
Edades de 18 a 130 · Todos los sexos · Actualizado el 5 oct 2026 · NCT05417594Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- Cedars-Sinai Medical Center, Los Angeles
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
- y 1 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT07001748Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- PCR Oncology, Arroyo Grande
- Mercy Cancer Center - Carmichael, Carmichael
- Mercy San Juan Medical Center, Carmichael
- y 15 más
ReclutandoFase 2
Todas las edades · Todos los sexos · Actualizado el 5 oct 2026 · NCT05564377Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Research Site, Duarte
- Research Site, Irvine
ReclutandoFase 1/2
Edades de 18 a 130 · Todos los sexos · Actualizado el 5 oct 2026 · NCT05797168A Study of PHST001 in Advanced Solid Tumors
- Precision NextGen Oncology & Research Center, Beverly Hills
- USC Norris Comprehensive Cancer Center, Los Angeles
- Stanford University School of Medicine, Palo Alto
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT06840886A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- City of Hope National Medical Center, Duarte
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06465069The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of San Diego Moores Cancer Center, La Jolla
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06760819Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- y 10 más
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT07059884A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- City of Hope, Duarte
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06172478A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of California - Los Angeles, Los Angeles
ReclutandoFase 1
Edades de 19 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06586957A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Start Los Angeles /ID# 281533, Los Angeles
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 1 oct 2026 · NCT07024784A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
- City of Hope National Medical Center /ID# 281381, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 280914, Irvine
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07278336A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Duarte
- Research Site, Los Angeles
- Research Site, Newport Beach
- y 1 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT05877599A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- UCLA - University of California Los Angeles Medical Center /ID# 274566, Los Angeles
- Scripps Md Anderson - Prebys Cancer Center /ID# 276891, San Diego
- California Pacific Medical Center - Van Ness Campus /ID# 275329, San Francisco
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 29 sept 2026 · NCT06890338DESTINY-PANTUMOUR04
- Research Site, San Diego
ReclutandoEstudio observacional
Edades de 18 a 130 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07124000Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- University of California San Diego, La Jolla
- Stanford University, Palo Alto
- UCLA Medical Center, Santa Monica
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT04981119A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, Santa Monica
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07229313A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- City of Hope Comprehensive Cancer Center, Duarte
- The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
- Chao Family Comprehensive Cancer Center, Orange
ReclutandoFase 1/2
Edades de 18 en adelante · Mujeres · Actualizado el 24 sept 2026 · NCT04590326Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, Los Angeles
- Research Site, Santa Rosa
ReclutandoFase 2
Edades de 18 a 130 · Todos los sexos · Actualizado el 23 sept 2026 · NCT05489211A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center, Burbank
- City of Hope, Duarte, Duarte
- City of Hope Lennar, Irvine
- y 6 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07213804A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford University Medical Center, Stanford
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07213791A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- UC San Diego Health - Moores Cancer Center /ID# 277574, La Jolla
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 22 sept 2026 · NCT07059845Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- UC IRVINE Health, Orange
- UC Davis Comprehensive Cancer Center, Sacramento
- Stanford Cancer Institute, Stanford
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Beverly Hills Cancer Center, Beverly Hills
- City of Hope Cancer Center, Duarte
- University of California Irvine Medical Center, Orange
- y 1 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT05983432BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- City of Hope National Medical Center, Duarte
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT04752826A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- John Muir Health Cancer Center ( Site 0069), Walnut Creek
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 17 sept 2026 · NCT07318558A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- City of Hope, Duarte
- City of Hope, Irvine, Irvine
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07109726Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- City of Hope Medical Center, Duarte
- Providence Medical Foundation, Fullerton
- University of California, San Diego-Moores Cancer Center, La Jolla
- y 3 más
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 15 sept 2026 · NCT07214779A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- University of California, Los Angeles Medical Center, Los Angeles
- Scripps Healthscripps Mercy Hospital Prebys Cancer Center, San Diego
ReclutandoFase 2
Edades de 18 a 99 · Mujeres · Actualizado el 15 sept 2026 · NCT07023627ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of California, San Diego, La Jolla
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Redwood City, Redwood City
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT05059444Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- UC San Diego Health, La Jolla
- Cedars Sinai Medical Center, Los Angeles
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 14 sept 2026 · NCT06787612A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Santa Monica
- Research Site, Santa Rosa
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT05123482Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
- Stanford University, Palo Alto
ReclutandoFase 1
Edades de 18 en adelante · Mujeres · Actualizado el 10 sept 2026 · NCT06646627Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- City of Hope, Duarte
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
- y 1 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 sept 2026 · NCT06293898A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT06400472A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- UCSF Medical Center at Mission Bay ( Site 0013), San Francisco
- John Muir Health Cancer Center ( Site 0016), Walnut Creek
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 3 sept 2026 · NCT06824467FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- UC San Diego Moores Cancer Center, La Jolla
- University of Southern California, Los Angeles
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07216105Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
- Start Cal, Los Angeles
ReclutandoFase 1/2
Edades de 18 en adelante · Mujeres · Actualizado el 1 sept 2026 · NCT07736937De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.